Restylane Defyne - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

Representative image illustrating rising takeover speculation around Papa John’s International, Inc., as renewed private equity interest and a reported $65-per-share bid from TriArtisan Capital Advisors push the PZZA stock back into focus amid ongoing turnaround efforts.

Papa John’s agrees to explore sale as renewed private equity interest lifts PZZA

Read More

5 minute read

Healthcare Industry News

What Galderma’s Japan launch of Restylane Defyne and Refyne means for the Asia aesthetics market

Galderma launches Restylane Defyne and Refyne in Japan, expanding OBT injectables. Find out what this means for Asia growth and investors.

byPallavi Madhiraju

February 11, 2026

web analytics